Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 2
2016 1
2017 4
2018 3
2019 3
2020 1
2021 5
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries.
Zozaya N, Villaseca J, Fernández I, Abdalla F, Cadenas-Noreña B, Calleja MÁ, Gómez-Pajuelo P, Mestre-Ferrándiz J, Oliva-Moreno J, Trillo JL, Hidalgo-Vega Á. Zozaya N, et al. Among authors: calleja ma. Appl Health Econ Health Policy. 2024 May;22(3):297-313. doi: 10.1007/s40258-023-00867-9. Epub 2024 Jan 12. Appl Health Econ Health Policy. 2024. PMID: 38214848 Review.
Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.
Valdés-Delgado T, Aguado-Paredes A, Merino-Bohórquez V, Martín-Manzanares J, Alonso MM, Maldonado B, Castro L, Belvis M, Benítez B, Caunedo Á, Calleja MÁ, Argüelles-Arias F. Valdés-Delgado T, et al. Among authors: calleja ma. Dig Dis Sci. 2024 Jan;69(1):228-234. doi: 10.1007/s10620-023-08139-1. Epub 2023 Nov 9. Dig Dis Sci. 2024. PMID: 37943382 Free PMC article.
Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.
Villanueva V, Serratosa JM, Toledo M, Ángel Calleja M, Navarro A, Sabaniego J, Pérez-Domper P, Álvarez-Barón E, Subías S, Gil A. Villanueva V, et al. Among authors: angel calleja m. Epilepsy Behav. 2023 Feb;139:109054. doi: 10.1016/j.yebeh.2022.109054. Epub 2023 Jan 3. Epilepsy Behav. 2023. PMID: 36603345 Free article.
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain.
Ángel Calleja M, Navarro A, Serratosa JM, Toledo M, Villanueva V, Subías Labazuy S, Gil A. Ángel Calleja M, et al. Expert Rev Pharmacoecon Outcomes Res. 2022 Oct;22(7):1127-1136. doi: 10.1080/14737167.2022.2107507. Epub 2022 Aug 3. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35904256 Free article.
Potential clinical biomarkers in rheumatoid arthritis with an omic approach.
Puentes-Osorio Y, Amariles P, Calleja MÁ, Merino V, Díaz-Coronado JC, Taborda D. Puentes-Osorio Y, et al. Among authors: calleja ma. Auto Immun Highlights. 2021 May 31;12(1):9. doi: 10.1186/s13317-021-00152-6. Auto Immun Highlights. 2021. PMID: 34059137 Free PMC article. Review.
25 results